Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279279 · ClinicalTrials.gov registry record · NA
PREPARE - Primary Prevention Parameters Evaluation
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 700
- Enrollment target
NCT00279279 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 700 participants.
The verdict
NCT00279279, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
Study Summary
The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The information learned from this study could be used to guide physicians in future ICD or CRT device programming.
Interventions
- DEVICE Implanted Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279279
The ClinicalTrials.gov registry entry for NCT00279279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implanted Device is the first listed.
NCT00279279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279279 about?
NCT00279279 is a clinical study titled "PREPARE - Primary Prevention Parameters Evaluation". The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The ...
What is the current status of trial NCT00279279?
This trial is currently completed. It is a NA study. The enrollment target is 700 participants. The study started on 2003-10. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00279279?
The interventions under investigation include: Implanted Device (DEVICE).
Who is sponsoring clinical trial NCT00279279?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.